UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors

PloS one, 2018-03, Vol.13 (3), p.e0193773-e0193773

2018

Volltextzugriff (PDF)

Low-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controller

PloS one, 2012-02, Vol.7 (2), p.e31928-e31928

2012

Volltextzugriff (PDF)

HIV-1 inhibiting capacity of novel forms of presentation of GB virus C peptide domains is enhanced by coordination to gold compounds

Current medicinal chemistry, 2014-01, Vol.21 (2), p.238-250

2014

Volltextzugriff (PDF)

Systematic analysis of intracellular trafficking motifs located within the cytoplasmic domain of simian immunodeficiency virus glycoprotein gp41

PloS one, 2014-12, Vol.9 (12), p.e114753

2014

Volltextzugriff (PDF)

Glycosystems in nanotechnology: Gold glyconanoparticles as carrier for anti-HIV prodrugs

Beilstein journal of organic chemistry, 2014-06, Vol.10 (1), p.1339-1346

2014

Volltextzugriff (PDF)

Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant

PloS one, 2018-12, Vol.13 (12), p.e0208345-e0208345

2018

Volltextzugriff (PDF)

Structural Study of a New HIV‐1 Entry Inhibitor and Interaction with the HIV‐1 Fusion Peptide in Dodecylphosphocholine Micelles

Chemistry : a European journal, 2017-08, Vol.23 (48), p.11703-11713

2017

Volltextzugriff (PDF)

Gold Nanoparticles Coated with Oligomannosides of HIV-1 Glycoprotein gp120 Mimic the Carbohydrate Epitope of Antibody 2G12

Journal of molecular biology, 2011-07, Vol.410 (5), p.798-810

2011

Volltextzugriff (PDF)

The Association of HIV-1 Neutralization in Aviremic Children and Adults with Time to ART Initiation and CD4+/CD8+ Ratios

Vaccines (Basel), 2023-12, Vol.12 (1), p.8

2023

Volltextzugriff (PDF)

Evaluation of the Thermal Stability of a Vaccine Prototype Based on Virus-like Particle Formulated HIV-1 Envelope

Vaccines (Basel), 2022-03, Vol.10 (4), p.484

2022

Volltextzugriff (PDF)

Balancing Selection and the Evolution of Functional Polymorphism in Old World Monkey TRIM5α

Proceedings of the National Academy of Sciences - PNAS, 2006-12, Vol.103 (50), p.19134-19139

2006

Volltextzugriff (PDF)

HIV-1 Dual Infected LTNP-EC Patients Developed an Unexpected Antibody Cross-Neutralizing Activity

PloS one, 2015-08, Vol.10 (8), p.e0134054-e0134054

2015

Volltextzugriff (PDF)

Evolution of Broadly Cross-Reactive HIV-1-Neutralizing Activity: Therapy-Associated Decline, Positive Association with Detectable Viremia, and Partial Restoration of B-Cell Subpopulations

Journal of Virology, 2013-11, Vol.87 (22), p.12227-12236

2013

Volltextzugriff (PDF)

A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120

Virology (New York, N.Y.), 2007-04, Vol.360 (2), p.329-340

2007

Volltextzugriff (PDF)

Expansion of antibody secreting cells and modulation of neutralizing antibody activity in HIV infected individuals undergoing structured treatment interruptions

Journal of translational medicine, 2013-02, Vol.11 (1), p.48-48, Article 48

2013

Volltextzugriff (PDF)

In vitro analysis of human immunodeficiency virus type 1 resistance to nevirapine and fitness determination of resistant variants

Journal of general virology, 2002-01, Vol.83 (1), p.93-101

2002

Volltextzugriff (PDF)

Drastic Fitness Loss in Human Immunodeficiency Virus Type 1 upon Serial Bottleneck Events

Journal of Virology, 1999-04, Vol.73 (4), p.2745-2751

1999

Volltextzugriff (PDF)

226 Glycosylation of gp41 of Simian Immunodeficiency Virus Shields Epitopes That Can Be Targets for Neutralizing Antibodies

Journal of acquired immune deficiency syndromes (1999), 2009-06, Vol.51 (Supplement 2)

2009

Volltextzugriff (PDF)

Immunization with Single-Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIVmac239

PLoS pathogens, 2009-01, Vol.5 (1), p.e1000272

2009

Volltextzugriff (PDF)

Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses

Journal of virology, 2022-01, Vol.96 (1), p.e0134321-e0134321

2022

Volltextzugriff (PDF)

Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys

Nature medicine, 2009-08, Vol.15 (8), p.901-906

2009

Volltextzugriff (PDF)

Unusual Distribution of Mutations Associated with Serial Bottleneck Passages of Human Immunodeficiency Virus Type 1

Journal of Virology, 2000-10, Vol.74 (20), p.9546-9552

2000

Volltextzugriff (PDF)

Lipid raft-like liposomes used for targeted delivery of a chimeric entry-inhibitor peptide with anti-HIV-1 activity

Nanomedicine, 2017-02, Vol.13 (2), p.601-609

2017

Volltextzugriff (PDF)

Immunization with Single-Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIVmac239: e1000272

PLoS pathogens, 2009-01, Vol.5 (1)

2009

Volltextzugriff (PDF)

Systematic Analysis of Intracellular Trafficking Motifs Located within the Cytoplasmic Domain of Simian Immunodeficiency Virus Glycoprotein gp41: e114753

PloS one, 2014-12, Vol.9 (12)

2014

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

ThemaMicrobiology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(35)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Humans
(18)
Life Sciences & Biomedicine
(17)
Hiv
(13)
Human Immunodeficiency Virus
(12)
Vaccines
(11)
Viruses
(9)
Human Immunodeficiency Virus 1
(8)
Virology
(8)
Acquired Immune Deficiency Syndrome
(7)
Aids
(7)
Antibodies
(7)
Hiv-1 - Genetics
(7)
Science & Technology - Other Topics
(7)
Hiv-1
(6)
Hiv-1 - Immunology
(6)
Infections
(6)
Multidisciplinary Sciences
(6)
Neutralization Tests
(6)
Antibodies, Neutralizing - Immunology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors

Low-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controller

HIV-1 inhibiting capacity of novel forms of presentation of GB virus C peptide domains is enhanced by coordination to gold compounds

Systematic analysis of intracellular trafficking motifs located within the cytoplasmic domain of simian immunodeficiency virus glycoprotein gp41

Glycosystems in nanotechnology: Gold glyconanoparticles as carrier for anti-HIV prodrugs

Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant

Structural Study of a New HIV‐1 Entry Inhibitor and Interaction with the HIV‐1 Fusion Peptide in Dodecylphosphocholine Micelles

Gold Nanoparticles Coated with Oligomannosides of HIV-1 Glycoprotein gp120 Mimic the Carbohydrate Epitope of Antibody 2G12

The Association of HIV-1 Neutralization in Aviremic Children and Adults with Time to ART Initiation and CD4+/CD8+ Ratios

Evaluation of the Thermal Stability of a Vaccine Prototype Based on Virus-like Particle Formulated HIV-1 Envelope

Balancing Selection and the Evolution of Functional Polymorphism in Old World Monkey TRIM5α

HIV-1 Dual Infected LTNP-EC Patients Developed an Unexpected Antibody Cross-Neutralizing Activity

Evolution of Broadly Cross-Reactive HIV-1-Neutralizing Activity: Therapy-Associated Decline, Positive Association with Detectable Viremia, and Partial Restoration of B-Cell Subpopulations

A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120

Expansion of antibody secreting cells and modulation of neutralizing antibody activity in HIV infected individuals undergoing structured treatment interruptions

In vitro analysis of human immunodeficiency virus type 1 resistance to nevirapine and fitness determination of resistant variants

Drastic Fitness Loss in Human Immunodeficiency Virus Type 1 upon Serial Bottleneck Events

226 Glycosylation of gp41 of Simian Immunodeficiency Virus Shields Epitopes That Can Be Targets for Neutralizing Antibodies

Immunization with Single-Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIVmac239

Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses

Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys

Unusual Distribution of Mutations Associated with Serial Bottleneck Passages of Human Immunodeficiency Virus Type 1

Lipid raft-like liposomes used for targeted delivery of a chimeric entry-inhibitor peptide with anti-HIV-1 activity

Immunization with Single-Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIVmac239: e1000272

Systematic Analysis of Intracellular Trafficking Motifs Located within the Cytoplasmic Domain of Simian Immunodeficiency Virus Glycoprotein gp41: e114753

Aktive Filter

Suchergebnisse filtern